Article Details

Harbour BioMed's Batoclimab (HBM9161) Receives China CDE Breakthrough Therapy ...

Retrieved on: 2021-01-28 04:41:10

Tags for this article:

Click the tags to see associated articles and topics

Harbour BioMed's Batoclimab (HBM9161) Receives China CDE Breakthrough Therapy .... View article details on hiswai:

Excerpt

... fully human anti-FcRn monoclonal antibody (mAb), for the treatment of adult ... immune cell engager technology for developing bispecific antibodies.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo